• No notifications yet.
  • Sign Out
logo image
  • logo image
Registered User? Login

The community gives you the chance to connect and engage with delegates attending this event.

Access to the community is available for registered attendees only. 

If you have already registered, please join using the link below. To register for the event please follow the 'Register for free' button and summit your details. Please contact ftlive@ft.com with any questions.

Forgot Password?
Sign Up
loader image
New User? Sign Up

The community gives you the chance to connect and engage with delegates attending this event.

Access to the community is available for registered attendees only. 

If you have already registered, please join using the link below. To register for the event please follow the 'Register for free' button and summit your details. Please contact ftlive@ft.com with any questions.

Forgot Password?
Login
loader image


    Collaborating On Cancer Care And Prevention

    How can private and public organisations work together to improve access?

     21 November 2023 |  Evening Briefing | Dubai

    Shangri-La Dubai

    WATCH ON-DEMAND

    Presented by
    Partner logo
    In Partnership with
    Partner logo

    How private and public organisations can work together to improve access

    As global demand for healthcare rises and new treatments come to market, pressure is intensifying on how and what services are delivered. Cancer care is a prime example, with the overall volume of patients growing due to aging populations, and many health systems struggling to deliver increasingly advanced therapies with limited resources. The dual challenge is to make progress on prevention while providing access to the right treatments in a way that is efficient and affordable. 

    Closer collaboration between industry and healthcare providers has the potential to improve both cancer prevention and access to treatment. What more can be done to support prevention? How can public-private partnerships lead to better cancer care? What role does each stakeholder in the healthcare ecosystem have to play? What are some good examples? Should employers and private sector stakeholders play a bigger role in supporting those with cancer? 

    Join the Financial Times in partnership with MSD to explore how stakeholders across the healthcare and life sciences sector are working to improve cancer prevention, care and outcomes. Expert speakers will share insights into the solutions and approaches being explored and implemented within health systems in the Middle East, mainly focusing on GCC, Egypt and the Levant.

    SEE THE AGENDA

    World-Class Business Leaders and Speakers

    speaker image
    M
    Majed Mohammed
    Advocacy & Scientific Affairs Executive
    Friends of Cancer Patients (FOCP) - UAE
    speaker image
    AM
    Ashraf Mallak
    AVP & Managing Director
    MSD GCC
    speaker image
    DK
    Dana Kansou
    Manager for Distribution and Strategic Partnerships
    Dubai Insurance Company
    image placeholder
    H
    Hari Das
    Chief People Officer
    King's College Hospital London, UAE
    speaker image
    VF
    Veronica Foote
    Head of Policy and Consulting
    Working With Cancer® (WWC)
    speaker image
    HA
    Hazem Abdel Samie
    Managing Director
    MSD Egypt Cluster
    speaker image
    DH
    Dr Syed Hammad Tirmazy
    Consultant Clinical Oncologist and Head of the Medical Oncology Department
    Dubai Hospital, Dubai Health
    speaker image
    MP
    Michael Peel
    Science Editor
    Financial Times

    Industry Experts Will Explore

     Public - Private Partnerships (PPPs)

    What are the key considerations when designing PPPs for the healthcare sector and specifically for cancer? How attractive is it to private sector investors? What are the key measures of success in terms of prevention and progressing access to care?  

    Cancer Prevention and Access to Care

    How can employers play a role in disease and treatment awareness among their employees, supporting prevention, screening and cancer care? Can multinationals work as a catalyst for health equity among their employees? What incentive is there for employers to do so?

    Work Culture for Employees with Cancer 

    What progress is already being made towards building a more open and supportive culture at work for employees with cancer? What are some successful examples of private employers putting cancer prevention promises into action? 

    Digital pass

    © Financial Times Live

    FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice

                    

    LEGAL

    FT Live Website Terms of Use
    Slavery Statement & Policies
    Contact us



    FT Live Delegate Terms & Conditions
    Privacy policy
    Cookie policy

Contact the organizer
Contact the organizer